- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x SAM: S-ADENOSYLMETHIONINE
- 21 x EDO: 1,2-ETHANEDIOL
EDO.2: 7 residues within 4Å:- Chain A: P.62, Y.63, N.64, M.65, T.91, G.92, T.93
Ligand excluded by PLIPEDO.3: 7 residues within 4Å:- Chain A: D.133, T.136, K.146, E.147, G.148, F.149, F.150
Ligand excluded by PLIPEDO.5: 6 residues within 4Å:- Chain A: H.119, T.120, A.121, V.289, I.290, S.291
Ligand excluded by PLIPEDO.6: 6 residues within 4Å:- Chain A: K.46, K.170, N.198, S.201, E.203
- Ligands: EDO.10
Ligand excluded by PLIPEDO.7: 7 residues within 4Å:- Chain A: K.24, N.138, V.139, K.141, N.143, E.173, H.174
Ligand excluded by PLIPEDO.8: 2 residues within 4Å:- Chain A: E.23, K.24
Ligand excluded by PLIPEDO.9: 5 residues within 4Å:- Chain A: A.34, T.35, S.240, S.241, Y.242
Ligand excluded by PLIPEDO.10: 6 residues within 4Å:- Chain A: Y.132, K.137, S.201, S.202
- Ligands: EDO.6, 01.18
Ligand excluded by PLIPEDO.11: 3 residues within 4Å:- Chain A: T.35, L.36, K.38
Ligand excluded by PLIPEDO.12: 4 residues within 4Å:- Chain A: K.38, G.39
- Chain B: K.44, A.105
Ligand excluded by PLIPEDO.13: 6 residues within 4Å:- Chain A: V.118, H.119, T.120, F.156, Q.159, K.160
Ligand excluded by PLIPEDO.14: 5 residues within 4Å:- Chain A: Q.158, D.179, K.182, L.183, H.186
Ligand excluded by PLIPEDO.15: 6 residues within 4Å:- Chain A: A.10, Y.53, T.56, L.57, W.189
- Ligands: MES.4
Ligand excluded by PLIPEDO.16: 3 residues within 4Å:- Chain A: T.117, D.293, L.295
Ligand excluded by PLIPEDO.17: 7 residues within 4Å:- Chain A: R.66, N.122, K.123, R.283, E.284, N.285, N.286
Ligand excluded by PLIPEDO.19: 7 residues within 4Å:- Chain A: G.73, S.74, D.99, N.101, D.102, F.103
- Ligands: SAM.1
Ligand excluded by PLIPEDO.20: 3 residues within 4Å:- Chain A: N.101, D.102, I.112
Ligand excluded by PLIPEDO.21: 6 residues within 4Å:- Chain A: L.163, L.262, K.263, E.264, I.267, I.282
Ligand excluded by PLIPEDO.24: 3 residues within 4Å:- Chain B: D.92, T.112, N.115
Ligand excluded by PLIPEDO.25: 1 residues within 4Å:- Chain B: M.64
Ligand excluded by PLIPEDO.27: 5 residues within 4Å:- Chain B: I.39, T.40, N.41, R.79
- Ligands: IMD.26
Ligand excluded by PLIP- 1 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID
- 1 x 01: 7-(2-chloroethyl)-1,3-dimethyl-purine-2,6-dione
01.18: 9 residues within 4Å:- Chain A: K.24, C.25, D.26, L.27, Y.30, K.137, V.139, E.173
- Ligands: EDO.10
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:L.27, A:K.137
- pi-Stacking: A:Y.30, A:Y.30
- 2 x ZN: ZINC ION
ZN.22: 4 residues within 4Å:- Chain B: C.75, C.78, H.84, C.91
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.75, B:C.78, B:H.84, B:C.91
ZN.23: 4 residues within 4Å:- Chain B: C.118, C.121, C.129, C.131
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.118, B:C.121, B:C.129, B:C.131
- 1 x IMD: IMIDAZOLE
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kremling, V. et al., Crystal structures of SARS-CoV-2 methyltransferase nsp10-16 with Cap0-site binders. To Be Published
- Release Date
- 2024-09-25
- Peptides
- 2'-O-methyltransferase nsp16: A
Non-structural protein 10: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x SAM: S-ADENOSYLMETHIONINE
- 21 x EDO: 1,2-ETHANEDIOL
- 1 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID
- 1 x 01: 7-(2-chloroethyl)-1,3-dimethyl-purine-2,6-dione
- 2 x ZN: ZINC ION
- 1 x IMD: IMIDAZOLE
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kremling, V. et al., Crystal structures of SARS-CoV-2 methyltransferase nsp10-16 with Cap0-site binders. To Be Published
- Release Date
- 2024-09-25
- Peptides
- 2'-O-methyltransferase nsp16: A
Non-structural protein 10: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B